Global Nucleic Acid Detection Reagents Market Size, Share, and Trends Analysis Report, By Type (Polymerase Chain Reaction (PCR), Transcription-mediated Amplification (TMA), Whole Genome Sequencing, and Ligase Chain Reaction (LCR)), By Application (Disease Detection, Food & Beverages Testing, and Others), By End-user (Hospitals, Diagnostic Centers, and Others), Forecast (2022-2028)

The global nucleic acid detection reagents market is anticipated to grow at a considerable CAGR of 7.1% during the forecast period (2022-2028). Nucleic acid detection reagents are used in various testing, including PCR, LCR, and others for their application in the disease detection of several diseases, including infectious diseases, cancer, and genetic diseases. The major factor attributing to the growth of the global nucleic acid detection reagents market includes the rising prevalence of cancer globally. According to the World Cancer Research Fund (WCRF), around 18.1 million people are diagnosed with cancer in 2020 globally. Among these, around 9.3 million patients were men and 8.8 million patients are women. The nucleic acid detection reagents have a major application in the PCR method for detecting small cancer cells that are missed by other detection processes.

In addition, the application of nucleic acid detection reagents in disease detection is increasing due to the increasing prevalence of genetic diseases, including genetic disorders, and congenital abnormalities. According to the World Health Organization (WHO), around 2% to 5% of all live births are diagnosed with any one genetic disorder or congenital abnormalities. This estimation accounts for around 30% of pediatric hospital admission and childhood mortality of around 50% of patients. Furthermore, the application of nucleic acid detection reagents has seen significant growth due to the outbreak of the COVID-19 pandemic in 2020. The PCR test is used in the disease detection of COVID-19 using nucleic acid reagents as a platform.

The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market. For instance, in March 2022, the National Medical Products Administration (NMPA) of China approved 12 antigen test kits for the detection of COVID-19 infection. These kits are based on a nucleic acid reagents platform that is considered beneficial for increasing COVID-19 cases in the country.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
  • By End-user
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Thermo Fisher Scientific Inc., Merck Group, Alta Bioscience Ltd., General Electic Co., and Enzo Life Sciences, Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Nucleic Acid Detection Reagents Market Report by Segment

By Type

• Polymerase Chain Reaction (PCR)
• Ligase Chain Reaction (LCR)
• Transcription-mediated Amplification (TMA)
• Whole Genome Sequencing

By Application

• Disease Detection
• Food and Beverages Testing
• Others

By End-user

• Hospitals
• Diagnostic Centers
• Others

Global Nucleic Acid Detection Reagents Market Report by Region

North America

• The United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa